Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2006 1
2008 1
2009 3
2011 5
2012 3
2013 2
2014 1
2015 2
2016 4
2017 7
2018 5
2019 1
2020 1
2021 3
2022 5
2023 5
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
The Vascular Impairment of Cognition Classification Consensus Study.
Skrobot OA, O'Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group; Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Skrobot OA, et al. Alzheimers Dement. 2017 Jun;13(6):624-633. doi: 10.1016/j.jalz.2016.10.007. Epub 2016 Dec 10. Alzheimers Dement. 2017. PMID: 27960092 Free article.
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.
Skrobot OA, Black SE, Chen C, DeCarli C, Erkinjuntti T, Ford GA, Kalaria RN, O'Brien J, Pantoni L, Pasquier F, Roman GC, Wallin A, Sachdev P, Skoog I; VICCCS group; Ben-Shlomo Y, Passmore AP, Love S, Kehoe PG. Skrobot OA, et al. Alzheimers Dement. 2018 Mar;14(3):280-292. doi: 10.1016/j.jalz.2017.09.007. Epub 2017 Oct 19. Alzheimers Dement. 2018. PMID: 29055812 Free article.
Temporal order of clinical and biomarker changes in familial frontotemporal dementia.
Staffaroni AM, Quintana M, Wendelberger B, Heuer HW, Russell LL, Cobigo Y, Wolf A, Goh SM, Petrucelli L, Gendron TF, Heller C, Clark AL, Taylor JC, Wise A, Ong E, Forsberg L, Brushaber D, Rojas JC, VandeVrede L, Ljubenkov P, Kramer J, Casaletto KB, Appleby B, Bordelon Y, Botha H, Dickerson BC, Domoto-Reilly K, Fields JA, Foroud T, Gavrilova R, Geschwind D, Ghoshal N, Goldman J, Graff-Radford J, Graff-Radford N, Grossman M, Hall MGH, Hsiung GY, Huey ED, Irwin D, Jones DT, Kantarci K, Kaufer D, Knopman D, Kremers W, Lago AL, Lapid MI, Litvan I, Lucente D, Mackenzie IR, Mendez MF, Mester C, Miller BL, Onyike CU, Rademakers R, Ramanan VK, Ramos EM, Rao M, Rascovsky K, Rankin KP, Roberson ED, Savica R, Tartaglia MC, Weintraub S, Wong B, Cash DM, Bouzigues A, Swift IJ, Peakman G, Bocchetta M, Todd EG, Convery RS, Rowe JB, Borroni B, Galimberti D, Tiraboschi P, Masellis M, Finger E, van Swieten JC, Seelaar H, Jiskoot LC, Sorbi S, Butler CR, Graff C, Gerhard A, Langheinrich T, Laforce R, Sanchez-Valle R, de Mendonça A, Moreno F, Synofzik M, Vandenberghe R, Ducharme S, Le Ber I, Levin J, Danek A, Otto M, Pasquier F, Santana I, Kornak J, Boeve BF, Rosen HJ, Rohrer JD, Boxer AL; Frontotempor… See abstract for full author list ➔ Staffaroni AM, et al. Nat Med. 2022 Oct;28(10):2194-2206. doi: 10.1038/s41591-022-01942-9. Epub 2022 Sep 22. Nat Med. 2022. PMID: 36138153 Free PMC article.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
Comprehensive cross-sectional and longitudinal analyses of plasma neurofilament light across FTD spectrum disorders.
Gendron TF, Heckman MG, White LJ, Veire AM, Pedraza O, Burch AR, Bozoki AC, Dickerson BC, Domoto-Reilly K, Foroud T, Forsberg LK, Galasko DR, Ghoshal N, Graff-Radford NR, Grossman M, Heuer HW, Huey ED, Hsiung GR, Irwin DJ, Kaufer DI, Leger GC, Litvan I, Masdeu JC, Mendez MF, Onyike CU, Pascual B, Ritter A, Roberson ED, Rojas JC, Tartaglia MC, Wszolek ZK, Rosen H, Boeve BF, Boxer AL; ALLFTD consortium; Petrucelli L. Gendron TF, et al. Among authors: bozoki ac. Cell Rep Med. 2022 Apr 19;3(4):100607. doi: 10.1016/j.xcrm.2022.100607. eCollection 2022 Apr 19. Cell Rep Med. 2022. PMID: 35492244 Free PMC article.
ASLPrep: a platform for processing of arterial spin labeled MRI and quantification of regional brain perfusion.
Adebimpe A, Bertolero M, Dolui S, Cieslak M, Murtha K, Baller EB, Boeve B, Boxer A, Butler ER, Cook P, Colcombe S, Covitz S, Davatzikos C, Davila DG, Elliott MA, Flounders MW, Franco AR, Gur RE, Gur RC, Jaber B, McMillian C; ALLFTD Consortium; Milham M, Mutsaerts HJMM, Oathes DJ, Olm CA, Phillips JS, Tackett W, Roalf DR, Rosen H, Tapera TM, Tisdall MD, Zhou D, Esteban O, Poldrack RA, Detre JA, Satterthwaite TD. Adebimpe A, et al. Nat Methods. 2022 Jun;19(6):683-686. doi: 10.1038/s41592-022-01458-7. Epub 2022 Jun 10. Nat Methods. 2022. PMID: 35689029 Free PMC article.
Federated learning for medical image analysis: A survey.
Guan H, Yap PT, Bozoki A, Liu M. Guan H, et al. Among authors: bozoki a. Pattern Recognit. 2024 Jul;151:110424. doi: 10.1016/j.patcog.2024.110424. Epub 2024 Mar 12. Pattern Recognit. 2024. PMID: 38559674
Analysis of conversion of Alzheimer's disease using a multi-state Markov model.
Zhang L, Lim CY, Maiti T, Li Y, Choi J, Bozoki A, Zhu DC; Key Laboratory of Applied Statistics of the Ministry of Education (KLAS); Alzheimer’s Disease Neuroimaging Initiative. Zhang L, et al. Among authors: bozoki a. Stat Methods Med Res. 2019 Sep;28(9):2801-2819. doi: 10.1177/0962280218786525. Epub 2018 Jul 24. Stat Methods Med Res. 2019. PMID: 30039745
47 results